Research graph
References from Treatment and outcome in non-Hodgkin's lymphoma patients with and without prevalent diabetes mellitus in a population-based cancer registry. Local targets link to admitted publications; unresolved targets remain external evidence.
Disease burden of diabetes mellitus type II in the Netherlands: incidence, prevalence and mortality
2001 · External reference
The growing burden of diabetes mellitus in the US elderly population
10.1001/archinternmed.2007.35 · 2008 · External reference
Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program
10.1634/theoncologist.12-1-20 · 2007 · External reference
Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s
10.1016/j.ejca.2007.12.015 · 2008 · External reference
Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis
10.1001/jama.2008.824 · 2008 · External reference
Prognostic impact of increasing age and co-morbidity in cancer patients: a population-based approach
10.1016/j.critrevonc.2005.04.008 · 2005 · External reference
A population-based study of severity of comorbidity among patients with non-Hodgkin's lymphoma: prognostic impact independent of International Prognostic Index
10.1111/j.1365-2141.2005.05508.x · 2005 · External reference
Diabetes mellitus associated with the occurrence and prognosis of non-Hodgkin's lymphoma
10.1097/01.cej.0000236253.93984.8f · 2007 · External reference
Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis
10.1002/ijc.22532 · 2007 · External reference
Independent prognostic effect of co-morbidity in lymphoma patients: results of the population-based Eindhoven Cancer Registry
10.1016/j.ejca.2005.01.010 · 2005 · External reference
Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin's lymphoma using CHOP versus CNOP chemotherapy
10.1200/jco.1995.13.10.2530 · 1995 · External reference
Therapy of follicular lymphoma
10.1007/s00108-007-1804-2 · 2007 · External reference
Rituximab in lymphoma: a systematic review and consensus practice guideline from Cancer Care Ontario
10.1016/j.ctrv.2006.10.005 · 2007 · External reference
Management of nodal diffuse large B-cell lymphomas: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation
2006 · External reference
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma
10.1056/nejmoa011795 · 2002 · External reference
Treatment of aggressive non-Hodgkin's lymphoma: a north American perspective
2005 · External reference
Chemotherapy-induced peripheral neuropathy
10.1007/pl00007853 · 2002 · External reference
Doxorubicin (adriamycin) cardiomyopathy
1983 · External reference
A comparison of the Charlson comorbidity index derived from medical record data and administrative billing data
10.1016/s0895-4356(98)00154-1 · 1999 · External reference
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation
10.1016/0021-9681(87)90171-8 · 1987 · External reference
Standards of medical care in diabetes-2010
2010 · External reference
Unresolved reference
2008 · External reference
Toxicity and response criteria of the Eastern Cooperative Oncology Group
10.1097/00000421-198212000-00014 · 1982 · External reference
Cancer Therapy Evaluation Program
2006 · External reference
Validity of the Ann Arbor staging classification for the non-Hodgkin's lymphomas
1977 · External reference
Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group
10.1200/jco.1999.17.4.1244 · 1999 · External reference
Follicular lymphoma international prognostic index
10.1182/blood-2003-12-4434 · 2004 · External reference
The International Non-Hodgkin's Lymphoma Prognostic Factors Project
1993 · External reference
Global prevalence of diabetes: estimates for the year 2000 and projections for 2030
10.2337/diacare.27.5.1047 · 2004 · External reference
Prevalence and incidence of Type 2 diabetes and its complications 1996–2003—estimates from a Swedish population-based study
10.1111/j.1464-5491.2008.02541.x · 2008 · External reference
Full accounting of diabetes and pre-diabetes in the U.S. population in 1988–1994 and 2005–2006
10.2337/dc08-1296 · 2009 · External reference
Prognostic factors for hematotoxicity of chemotherapy in aggressive non-Hodgkin's lymphoma
10.1093/annonc/mdm541 · 2008 · External reference
Incidence and predictors of low chemotherapy dose-intensity in aggressive non-Hodgkin's lymphoma: a nationwide study
10.1200/jco.2004.03.213 · 2004 · External reference
